YD Bio (YDES) Other Non-Current Liabilities (2024 - 2026)
YD Bio's (YDES) quarterly Other Non-Current Liabilities came in at $4.5 million in Q2 2026, down 69.87% quarter-over-quarter from $15.0 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Other Non-Current Liabilities for 3 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $15.0 million, up 397235.86% from the prior year.
- Other Non-Current Liabilities was $4.5 million for Q2 2026 at YD Bio, down from $15.0 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $15.0 million in Q4 2025 and troughed at $3773.0 in Q4 2024.
- A 3-year average of $6.5 million and a median of $4.5 million in 2026 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 397235.86% in 2025, down 397235.86% in 2025.
- Over 3 years, Other Non-Current Liabilities stood at $3773.0 in 2024, then soared by 397235.86% to $15.0 million in 2025, then slumped by 69.87% to $4.5 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $4.5 million (Q2 2026), $15.0 million (Q4 2025), and $3773.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.52 Mn |
| Dec 31, 2025 | 14.99 Mn |
| Dec 31, 2024 | 3,773.00 |
API Access
YD Bio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();